Roka Bioscience Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Roka Bioscience Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C5260
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Roka Bioscience Inc (Roka) is a manufacturer and distributor of molecular assays and instruments for food safety industry. The company offers products such as Atlas- automated molecular pathogen detection system, the listeria LSP detection assay, listeria monocytogenes Lmg2 detection assay, salmonella SEN detection assay, E.coli O157:H7 EG2 detection assay and STEC EG combo detection assay, among others. It provides pathogen solutions for various industries including beef, diary, pet food, poultry, and others. Roka also provides pathogen solutions for spice and ingredients market and ready to eat (rte) market. The company’s technology combines target capture, transcription- mediated amplification and hybridization protection assay, among others. Roka is head quartered in Warren, New Jersey, the US.

Roka Bioscience Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Roka Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Roka Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Roka Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Roka Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Roka Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Roka Bioscience Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Roka Bioscience Raises US$42 Million In Series E Financing 10
Partnerships 11
Roka Bioscience Enters into Licensing Agreement with MBio Diagnostics 11
Equity Offering 12
Roka Bioscience Raises USD22.5 million in Private Placement of Shares 12
Roka Bioscience Raises USD60 Million in IPO 13
Roka Bioscience Inc – Key Competitors 14
Roka Bioscience Inc – Key Employees 15
Roka Bioscience Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Financial Announcements 17
May 11, 2017: Roka Bioscience Reports First Quarter 2017 Financial Results 17
Mar 09, 2017: Roka Bioscience Reports Fourth Quarter and Full Year 2016 Financial Results 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Roka Bioscience Inc, Medical Equipment, Key Facts 2
Roka Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Roka Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Roka Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Roka Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Roka Bioscience Inc, Deals By Market, 2012 to YTD 2018 8
Roka Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Roka Bioscience Raises US$42 Million In Series E Financing 10
Roka Bioscience Enters into Licensing Agreement with MBio Diagnostics 11
Roka Bioscience Raises USD22.5 million in Private Placement of Shares 12
Roka Bioscience Raises USD60 Million in IPO 13
Roka Bioscience Inc, Key Competitors 14
Roka Bioscience Inc, Key Employees 15

List of Figures
Roka Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Roka Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Roka Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Roka Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Roka Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Roka Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Roka Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Roka Bioscience Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Roka Bioscience Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • iPass Inc.:企業の戦略的SWOT分析
    iPass Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Companhia Energetica de Sao Paulo (CESP6):企業の財務・戦略的SWOT分析
    Companhia Energetica de Sao Paulo (CESP6) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • CITIC Ltd (267)-エネルギー分野:企業M&A・提携分析
    Summary CITIC Limited (CITIC) is a conglomerate that is active in diverse business areas such as financial services, resources and energy, manufacturing, engineering contracting, and real estate and infrastructure. Its financial services include banking, trust, asset management, securities and insur …
  • Yaskawa Electric Corp:企業の戦略・SWOT・財務分析
    Yaskawa Electric Corp - Strategy, SWOT and Corporate Finance Report Summary Yaskawa Electric Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Syngen Biotech Co Ltd (8279)-製薬・医療分野:企業M&A・提携分析
    Summary Syngen Biotech Co Ltd (Syngen), a part of Standard Chem& Pharm Co Ltd, is a biotechnology company that specializes in strain identification, micro-organism fermentation, recovery, and purification. The company research, develops, manufactures and distributes active pharmaceutical ingredients …
  • Bioasis Technologies Inc (BTI):企業の財務・戦略的SWOT分析
    Summary Bioasis Technologies Inc (BTI) operates as a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents …
  • Eris Lifesciences Ltd (ERIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Eris Lifesciences Ltd (Eris Lifesciences) is a health care products and service provider. The company offers glimepride, telmisertan, methylcobalamin and combinations, vitamin d, rabeprazole, olmesartan, mecobalamin colecalciferol, teneligliptin, rosa canina extract, cilnidipine, atorvastati …
  • Penske Automotive Group, Inc.:企業のM&A・事業提携・投資動向
    Penske Automotive Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Penske Automotive Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • BlueScope Steel Ltd:企業のM&A・事業提携・投資動向
    BlueScope Steel Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BlueScope Steel Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Capsugel Inc:企業の戦略的SWOT分析
    Capsugel Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ems-Chemie Holding AG (EMSN):企業の財務・戦略的SWOT分析
    Summary Ems-Chemie Holding AG (Ems-Chemie) is a chemical company that manufactures and markets high performance polymers and specialty chemicals. The company's products include bonding products, polyamides, damping systems, sealants, coating products, thermoplastic material, technical fibers, and te …
  • Cellmid Ltd (CDY):医療機器:M&Aディール及び事業提携情報
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such a …
  • JSFC Sistema (AFKS):企業の財務・戦略的SWOT分析
    JSFC Sistema (AFKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Occidental Petroleum Corporation (OXY)-石油・ガス分野:企業M&A・提携分析
    Summary Occidental Petroleum Corporation (Occidental) is an oil and gas exploration and production company with integrated assets. The company is active in upstream exploration and production; midstream and marketing; and chemicals business. The oil and gas business explores for, develops and produc …
  • Aragen Bioscience Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aragen Bioscience Inc (Aragen), a subsidiary of GVK Biosciences Inc is a contract research organisation that provides preclinical contract research and development services. The company provides recombinant cell line and hybridoma development, cell culture and protein purification process de …
  • RPC Group PLC:企業の戦略・SWOT・財務分析
    RPC Group PLC - Strategy, SWOT and Corporate Finance Report Summary RPC Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ashok Leyland Limited:企業のM&A・事業提携・投資動向
    Ashok Leyland Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ashok Leyland Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Burlington Stores, Inc.:企業の戦略・SWOT・財務分析
    Burlington Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Burlington Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Novatek (NVTK):石油・ガス:M&Aディール及び事業提携情報
    Summary Novatek (Novatek) is an independent oil and gas company. The company explores, produces, processes, and markets natural gas and liquid hydrocarbons. Its licensed producing fields include, Yurkharovskoye, East-Tarkosalinskoye, Khancheyskoye, Olimpiyskiy, Yumantilskiy, Samburgskiy, North-Ureng …
  • China Resources Land Limited:企業の戦略・SWOT・財務情報
    China Resources Land Limited - Strategy, SWOT and Corporate Finance Report Summary China Resources Land Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆